Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer (HERO)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05705401 |
Recruitment Status :
Recruiting
First Posted : January 30, 2023
Last Update Posted : April 2, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HER2-positive Breast Cancer | Radiation: Standard of Care Adjuvant Breast Radiation Drug: Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation | Phase 3 |
The landmark trials that established breast conservation therapy (BCT) (breast-conserving surgery followed by adjuvant breast irradiation) as a suitable alternative to mastectomy were conducted in an era that predated biological subtyping of breast cancer and the use of HER2-directed therapies in patients with HER2+ cancers. These trials established adjuvant radiotherapy following breast-conserving surgery as necessary to maximize local control, yet, in the intervening years, overall outcomes have improved significantly owing to widespread adoption of screening mammography, resulting in a substantial reduction in average tumor size at diagnosis, as well as improvements in surgical techniques and, crucial for this proposal, the development of highly active systemic therapies.
Before the development of HER2-targeted therapies, patients with HER2-driven localized breast cancer had among the highest rates of local recurrence. However, with improved identification of these patients and the advent of HER2-directed therapies, outcomes have improved significantly, and trials have sought to optimize treatment to reduce the morbidity of both local and systemic treatment. Among the most salient of these examples is the APT trial, a single-arm adjuvant study that enrolled 410 breast cancer patients with HER2+ tumors ≤ 3cm in size and negative axillary nodes, who received adjuvant systemic therapy with weekly paclitaxel and trastuzumab for 12 weeks (TH) followed by 9 months of trastuzumab monotherapy. In addition to demonstrating a very low incidence of distant recurrence, among those on the trial who underwent BCT (lumpectomy and radiation, n = 244), only 2 local recurrence (LR) events have been reported after 7 years of follow-up (7-year LR = 1.2%), representing among the most favorable local outcomes of any breast cancer cohort studied to date. Confirmatory results are forthcoming from the ATEMPT trial, which evaluated the antibody-drug conjugate T-DM1 (ado-trastuzumab emtansine) (n=383) vs the TH regimen from the APT trial (n = 114), thus far showing only 3 LRs in each arm with a median 3-years of follow-up. Importantly, per the current standard of care for HER2+ patients undergoing BCT, all patients presumably received adjuvant breast radiotherapy.
The balance of the BCT literature, including a landmark meta-analysis by the Early Breast Cancer Trialists' Collaborative Group, suggests that adjuvant radiotherapy approximately halves the risk of local recurrence following lumpectomy across all analyzable subgroups. While the relative benefit appears constant across subgroups, the absolute benefit of adjuvant radiotherapy varies with the underlying risk. Taking the favorable results of the APT trial (1.2% 7-year LR), if one presumes that omission of radiotherapy yields a doubling or tripling of local recurrence (based on the observed RR of 0.5 - 0.66 for those receiving radiotherapy across the preponderance of historical trials), this population might have manifested a LR rate of 2.4 - 3.6% with the omission of radiotherapy. That is to say, the hypothesis is that administration of RT to APT patients undergoing BCT may have reduced the 7-year absolute risk of LR by only 1.2-2.4%. Through the identification of patients who are at low risk of LR, it may be acceptable for such patients to forego radiation. This hypothesis will be studied by evaluating omission of radiotherapy among patients with pT1N0 disease at breast-conserving surgery who receive adjuvant HER2-directed therapy (trastuzumab/paclitaxel preferred, other options per protocol), or with clinical tumors ≤ 3 cm and clinically negative axillary nodes (cN0) who achieve a pathologic complete response (pCR; ypT0N0) following preoperative (neoadjuvant) administration of HER2-directed therapy (trastuzumab/paclitaxel preferred, other options per protocol). It is expcted that the 5-year LR rate for this population omitting radiotherapy will be 2% or less, and that omission of radiation will not have a measurable impact on regional and distant recurrences or overall survival.
The practice of breast radiation oncology has benefited immensely from practice-changing trials that have refined the application of adjuvant radiotherapy since the early surgical studies determined whole breast radiotherapy to be necessary following lumpectomy. There are now several favorable breast cancer subtypes in which patients routinely forego radiotherapy after trials demonstrating modest benefits in terms of local recurrence and no impact on distant recurrence or survival, such as among small, low grade luminal cancers in older women and "good-risk" DCIS. Therefore, this will study the omission of radiotherapy among a population of HER2+ breast cancer patients who are now appreciated to also have favorable risk, so as to similarly weigh the attendant inconveniences, cost and morbidity of radiotherapy in light of an established absolute benefit, which may prove to be modest.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 1300 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Subjects who are receiving standard of care systemic HER2-targeted therapies are randomized to standard of care adjuvant breast radiation or no breast radiation |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer (HERO) |
Actual Study Start Date : | March 13, 2023 |
Estimated Primary Completion Date : | February 1, 2034 |
Estimated Study Completion Date : | February 1, 2037 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Standard of Care Adjuvant Breast Radiation
Patients continue to receive their current planned adjuvant breast radiation and systemic HER2-targeted therapies
|
Radiation: Standard of Care Adjuvant Breast Radiation
adjuvant breast radiotherapy per the current standard of care |
Active Comparator: Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
Patients continue to receive their current systemic HER2-targeted therapy without breast adjuvant radiation
|
Drug: Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
participants are randomized to continue their standard of care systemic HER2-targeted therapy without adjuvant breast radiotherapy |
- recurrence-free interval (RFI) [ Time Frame: From randomization to first recurrence event or censoring for the duration of the trial, at 10.5 years ]Time to recurrence event or censoring
- ipsilateral breast recurrence (IBR) for radiation omitting arm [ Time Frame: From randomization to first recurrence event or censoring for the duration of the trial , measured at year 7 ]Time to IBTR event or censoring
- ipsilateral breast recurrence (IBR) by treatment arm [ Time Frame: From randomization to first recurrence event or censoring for the duration of the trial at 10.5 years. ]Time to ipsilateral breast recurrence (IBR) by treatment arm.
- local regional recurrence (LRR) by treatment arm [ Time Frame: From randomization to first recurrence event or censoring for the duration of the trial at 10.5 years. ]Time to local regional recurrence (LRR) by treatment arm.
- disease-free survival (DFS) by treatment arm. [ Time Frame: From the time of randomization for the duration of the trial at 10.5 years. ]To determine disease-free survival (DFS) by treatment arm.
- overall survival (OS) by treatment arm. [ Time Frame: From the time of randomization for the duration of the trial at 10.5 years. ]To determine overall survival (OS) by treatment arm.
- patient-reported breast pain by treatment arm using the Breast Cancer Treatment Outcome Scale (BCTOS) [ Time Frame: At 3 years after randomization ]To evaluate whether there is a difference in patient-reported breast pain in patients who do and do not receive breast radiation in cohort A and cohort B. The BCTOS pain score has a range from 1-5 with higher scores indicating worse pain.
- patient-reported worry about recurrence by treatment arm using a the three-item worry about recurrence score [ Time Frame: At 3 years after randomization ]To evaluate whether there is a difference in patient-reported worry about recurrence in patients who do and do not receive breast radiation in cohort A and cohort B. The worry about recurrence score has a range from 1-5 with higher scores indicating more worry.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the U.S., authorization permitting release of personal health information.
-
female and male patients who have undergone breast conserving surgery and completed a minimum of 4 cycles (12 weeks) of neoadjuvant or adjuvant chemotherapy in combination with HER2-targeted therapy.
-≥ 40 years of age
- ECOG performance status of 0 ,1, or 2/Karnofsky performance status above 60
- Histologically or cytologically confirmed invasive breast carcinoma.
- tumor must have been determined to be HER2-positive by current ASCO/CAP guidelines based on local testing results.
- Patient must have undergone axillary staging, either sentinel node biopsy (SNB) or axillary lymph nodal dissection (ALND). In neoadjuvant patients, SNB following neoadjuvant therapy is strongly recommended. SNB prior to neoadjuvant therapy is discouraged, but patients are permitted if node negative (pN0).
- The following staging criteria must be met according to AJCC 8th edition criteria:
Adjuvant cohort : By pathologic evaluation, the patient's primary tumor must be </= 2 cm and ipsilateral nodes must be pN0. Surgical lumpectomy margins must be negative for invasive cancer and ductal carcinoma in situ (no ink on tumor).
Neoadjuvant cohort: Prior to neoadjuvant therapy, the patient's primary tumor must be < 3 cm by imaging studies, with negative axillary nodes (cN0) based on axillary U/S, CT, PET or MRI. Physical examination is not sufficient documentation of cN0 status; • Must be ypT0N0 at surgery (lumpectomy); patients with residual non-invasive disease (DCIS) in the surgical specimen (ypTis), are NOT eligible.
- For the Adjuvant cohort, adjuvant therapy must have consisted of a minimum of 4 cycles (12 weeks) of chemotherapy in combination with HER2-targeted therapy.
- For the Neoadjuvant cohort, neoadjuvant therapy must have consisted of a minimum of 4 cycles (12 weeks) of chemotherapy in combination with HER2-targeted therapy.- ; Patients who did not receive chemotherapy in the neoadjuvant setting are not eligible, even if they achieved pCR with their preoperative treatment; nor would these patients become eligible by receiving chemotherapy after surgery.
- In patients assigned to radiation therapy, treatment should start ≤ 12 weeks from surgery on the Neoadjuvant cohort and ≤ 8 weeks from the completion of chemotherapy on the Adjuvant cohort. Patients should continue HER2-targeted therapy during assigned study treatment (radiation or observation).
- Bilateral mammogram or MRI within 52 weeks prior to randomization.
- HIV-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization are eligible for this trial.
Exclusion Criteria:
- Definitive clinical or radiologic evidence of metastatic disease.
- On the Adjuvant cohort, patients with a primary tumor >2 cm on pathologic examination of the surgical specimen. On the Neoadjuvant cohort, patients with a primary tumor > 3 cm or with abnormal or suspicious ipsilateral axillary nodes by pretreatment imaging, unless demonstrated to be negative by cytologic or histologic examination.
- Pathologically positive axillary nodes at any time including of pN0(i+) or pN0(mol+) ypN0(i+) or ypN0(mol+) disease.
- Patient planning for or status-post mastectomy.
- Radiographically suspicious ipsilateral or contralateral axillary, supraclavicular, infraclavicular, or internal mammary lymph nodes, unless there is histological confirmation that these nodes are negative for metastatic disease.
- Suspicious microcalcifications, densities, or palpable abnormalities (in the ipsilateral or contralateral breast), or mass or non-mass enhancement on MRI (if performed) aside from the known cancer, unless biopsied and found to be benign.
- Non-epithelial breast malignancies such as sarcoma or lymphoma.
- Multicentric carcinoma (invasive cancer or DCIS) in more than one quadrant or separated by > 4 centimeters. If multifocal, all foci should be confined to a maximum tumor bed of 3 cm determined by pathological assessment.
- Paget's disease of the nipple.
- Synchronous (unilateral or bilateral) invasive breast cancer or DCIS. (Patients with synchronous and/or previous contralateral LCIS are eligible.)
- On the Adjuvant cohort, surgical margins that cannot be microscopically assessed or are positive at pathologic evaluation. (If surgical margins are rendered free of disease by re-excision, the patient is eligible).
- Treatment plan that includes regional nodal irradiation.
- Patients treated for a prior invasive breast malignancy are excluded. Contralateral DCIS ≥ 10 years prior to enrollment is permissible.
- Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial.
- Patients on oral, transdermal, or subdermal estrogen replacement (including all estrogen only and estrogen-progesterone formulas) are not eligible unless discontinued prior to randomization.
- Prior ipsilateral breast or thoracic RT for any condition (contralateral RT for DCIS ≥ 10 years prior to randomization is permitted).
- Active collagen vascular disease, specifically dermatomyositis with a CPK level above normal or with an active systemic lupus erythematosus, or scleroderma.
- Clinicians should consider whether any conditions would make this protocol unreasonably hazardous for the patient.
- Pregnancy or lactation at the time of randomization or intention to become pregnant during treatment. (Note: Pregnancy testing according to institutional standards for patients of childbearing potential must be performed within 14 days prior to randomization.)
- Use of any investigational product within 30 days prior to randomization.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05705401
Contact: Director, Department of Regulatory Affairs | 412-339-5300 | langerj@nrgoncology.org | |
Contact: Norman Wolmark, MD |
United States, Arizona | |
Cancer Center at Saint Joseph's | Recruiting |
Phoenix, Arizona, United States, 85004 | |
Contact: Site Public Contact 602-406-0777 Research-cancerinstitute@dignityhealth.org | |
Principal Investigator: Shahzad Siddique | |
Banner University Medical Center - Tucson | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact UACC-IIT@uacc.arizona.edu | |
Principal Investigator: Lora S. Wang | |
University of Arizona Cancer Center-North Campus | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact UACC-IIT@uacc.arizona.edu | |
Principal Investigator: Lora S. Wang | |
United States, California | |
Kaiser Permanente-Deer Valley Medical Center | Recruiting |
Antioch, California, United States, 94531 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Mission Hope Medical Oncology - Arroyo Grande | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 805-219-4673 ResearchInstituteInquiries@CommonSpirit.org | |
Principal Investigator: Shahzad Siddique | |
Sutter Auburn Faith Hospital | Recruiting |
Auburn, California, United States, 95602 | |
Contact: Site Public Contact NCIclinicaltrials@sutterhealth.org | |
Principal Investigator: Christopher U. Jones | |
Sutter Cancer Centers Radiation Oncology Services-Auburn | Recruiting |
Auburn, California, United States, 95603 | |
Contact: Site Public Contact NCIclinicaltrials@sutterhealth.org | |
Principal Investigator: Christopher U. Jones | |
Tower Cancer Research Foundation | Recruiting |
Beverly Hills, California, United States, 90211 | |
Contact: Site Public Contact towercancerresearch@toweroncology.com | |
Principal Investigator: Armando E. Giuliano | |
Sutter Cancer Centers Radiation Oncology Services-Cameron Park | Recruiting |
Cameron Park, California, United States, 95682 | |
Contact: Site Public Contact NCIclinicaltrials@sutterhealth.org | |
Principal Investigator: Christopher U. Jones | |
City of Hope Comprehensive Cancer Center | Recruiting |
Duarte, California, United States, 91010 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Jose G. Bazan | |
Kaiser Permanente Dublin | Recruiting |
Dublin, California, United States, 94568 | |
Contact: Site Public Contact 877-642-4691 | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Fremont | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Fresno Cancer Center | Recruiting |
Fresno, California, United States, 93720 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Fresno | Recruiting |
Fresno, California, United States, 93720 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
City of Hope at Irvine Lennar | Recruiting |
Irvine, California, United States, 92618 | |
Contact: Site Public Contact 877-467-3411 | |
Principal Investigator: Jose G. Bazan | |
City of Hope Antelope Valley | Recruiting |
Lancaster, California, United States, 93534 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Jose G. Bazan | |
Los Angeles General Medical Center | Recruiting |
Los Angeles, California, United States, 90033 | |
Contact: Site Public Contact 323-865-0451 uscnorrisinfo@med.usc.edu | |
Principal Investigator: Jason C. Ye | |
USC / Norris Comprehensive Cancer Center | Recruiting |
Los Angeles, California, United States, 90033 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Jason C. Ye | |
Cedars Sinai Medical Center | Recruiting |
Los Angeles, California, United States, 90048 | |
Contact: Site Public Contact 310-423-8965 | |
Principal Investigator: Armando E. Giuliano | |
Memorial Medical Center | Recruiting |
Modesto, California, United States, 95355 | |
Contact: Site Public Contact NCIclinicaltrials@sutterhealth.org | |
Principal Investigator: Christopher U. Jones | |
Kaiser Permanente-Modesto | Recruiting |
Modesto, California, United States, 95356 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente Oakland-Broadway | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Oakland | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
UC Irvine Health/Chao Family Comprehensive Cancer Center | Recruiting |
Orange, California, United States, 92868 | |
Contact: Site Public Contact 877-827-8839 ucstudy@uci.edu | |
Principal Investigator: Erin H. Healy | |
Stanford Cancer Institute Palo Alto | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Site Public Contact 650-498-7061 ccto-office@stanford.edu | |
Principal Investigator: Irene L. Wapnir | |
Pomona Valley Hospital Medical Center | Recruiting |
Pomona, California, United States, 91767 | |
Contact: Site Public Contact 909-865-9555 | |
Principal Investigator: Sri G. Gorty | |
Kaiser Permanente-Rancho Cordova Cancer Center | Recruiting |
Rancho Cordova, California, United States, 95670 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente- Marshall Medical Offices | Recruiting |
Redwood City, California, United States, 94063 | |
Contact: Site Public Contact 877-642-4691 | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Richmond | Recruiting |
Richmond, California, United States, 94801 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Rohnert Park Cancer Center | Recruiting |
Rohnert Park, California, United States, 94928 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Roseville | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Sutter Cancer Centers Radiation Oncology Services-Roseville | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact NCIclinicaltrials@sutterhealth.org | |
Principal Investigator: Christopher U. Jones | |
Sutter Roseville Medical Center | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact NCIclinicaltrials@sutterhealth.org | |
Principal Investigator: Christopher U. Jones | |
The Permanente Medical Group-Roseville Radiation Oncology | Recruiting |
Roseville, California, United States, 95678 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente Downtown Commons | Recruiting |
Sacramento, California, United States, 95814 | |
Contact: Site Public Contact 877-642-4691 kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Sutter Medical Center Sacramento | Recruiting |
Sacramento, California, United States, 95816 | |
Contact: Site Public Contact NCIclinicaltrials@sutterhealth.org | |
Principal Investigator: Christopher U. Jones | |
University of California Davis Comprehensive Cancer Center | Recruiting |
Sacramento, California, United States, 95817 | |
Contact: Site Public Contact 916-734-3089 | |
Principal Investigator: Xiao Zhao | |
Kaiser Permanente-South Sacramento | Recruiting |
Sacramento, California, United States, 95823 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
South Sacramento Cancer Center | Recruiting |
Sacramento, California, United States, 95823 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
California Pacific Medical Center-Pacific Campus | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact NCIclinicaltrials@sutterhealth.org | |
Principal Investigator: Christopher U. Jones | |
Kaiser Permanente-San Francisco | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Santa Teresa-San Jose | Recruiting |
San Jose, California, United States, 95119 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Stanford Cancer Center South Bay | Recruiting |
San Jose, California, United States, 95124 | |
Contact: Site Public Contact 650-498-7061 ccto-office@stanford.edu | |
Principal Investigator: Irene L. Wapnir | |
Kaiser Permanente San Leandro | Recruiting |
San Leandro, California, United States, 94577 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Pacific Central Coast Health Center-San Luis Obispo | Recruiting |
San Luis Obispo, California, United States, 93401 | |
Contact: Site Public Contact 805-219-4673 ResearchInstituteInquiries@CommonSpirit.org | |
Principal Investigator: Shahzad Siddique | |
Kaiser San Rafael-Gallinas | Recruiting |
San Rafael, California, United States, 94903 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Ridley-Tree Cancer Center | Recruiting |
Santa Barbara, California, United States, 93105 | |
Contact: Site Public Contact research@ridleytreecc.org | |
Principal Investigator: Shane E. Cotter | |
Kaiser Permanente Medical Center - Santa Clara | Recruiting |
Santa Clara, California, United States, 95051 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Mission Hope Medical Oncology - Santa Maria | Recruiting |
Santa Maria, California, United States, 93444 | |
Contact: Site Public Contact 805-219-4673 ResearchInstituteInquiries@CommonSpirit.org | |
Principal Investigator: Shahzad Siddique | |
Kaiser Permanente-Santa Rosa | Recruiting |
Santa Rosa, California, United States, 95403 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
City of Hope South Pasadena | Recruiting |
South Pasadena, California, United States, 91030 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Jose G. Bazan | |
Kaiser Permanente Cancer Treatment Center | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-South San Francisco | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Stockton | Recruiting |
Stockton, California, United States, 95210 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
City of Hope South Bay | Recruiting |
Torrance, California, United States, 90503 | |
Contact: Site Public Contact 877-467-3411 | |
Principal Investigator: Jose G. Bazan | |
Torrance Memorial Physician Network - Cancer Care | Recruiting |
Torrance, California, United States, 90505 | |
Contact: Site Public Contact 310-750-3300 courtney.steeneken@tmphysicians.com | |
Principal Investigator: Armando E. Giuliano | |
City of Hope Upland | Recruiting |
Upland, California, United States, 91786 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Jose G. Bazan | |
Kaiser Permanente Medical Center-Vacaville | Recruiting |
Vacaville, California, United States, 95688 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Vallejo | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
Kaiser Permanente-Walnut Creek | Recruiting |
Walnut Creek, California, United States, 94596 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Samantha A. Seaward | |
United States, Colorado | |
UCHealth University of Colorado Hospital | Recruiting |
Aurora, Colorado, United States, 80045 | |
Contact: Site Public Contact 720-848-0650 | |
Principal Investigator: Rachel A. Rabinovitch | |
Rocky Mountain Cancer Centers-Penrose | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
Principal Investigator: Shahzad Siddique | |
UCHealth Memorial Hospital Central | Recruiting |
Colorado Springs, Colorado, United States, 80909 | |
Contact: Site Public Contact 719-365-2406 | |
Principal Investigator: Rachel A. Rabinovitch | |
Memorial Hospital North | Recruiting |
Colorado Springs, Colorado, United States, 80920 | |
Contact: Site Public Contact 719-364-6700 | |
Principal Investigator: Rachel A. Rabinovitch | |
Saint Francis Cancer Center | Recruiting |
Colorado Springs, Colorado, United States, 80923 | |
Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
Principal Investigator: Shahzad Siddique | |
Poudre Valley Hospital | Recruiting |
Fort Collins, Colorado, United States, 80524 | |
Contact: Site Public Contact 970-297-6150 | |
Principal Investigator: Rachel A. Rabinovitch | |
Cancer Care and Hematology-Fort Collins | Recruiting |
Fort Collins, Colorado, United States, 80528 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Rachel A. Rabinovitch | |
UCHealth Greeley Hospital | Recruiting |
Greeley, Colorado, United States, 80631 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Rachel A. Rabinovitch | |
UCHealth Highlands Ranch Hospital | Recruiting |
Highlands Ranch, Colorado, United States, 80129 | |
Contact: Site Public Contact 720-848-0650 | |
Principal Investigator: Rachel A. Rabinovitch | |
Medical Center of the Rockies | Recruiting |
Loveland, Colorado, United States, 80538 | |
Contact: Site Public Contact 970-203-7083 | |
Principal Investigator: Rachel A. Rabinovitch | |
United States, Florida | |
John Fitzgerald Kennedy Medical Center | Recruiting |
Atlantis, Florida, United States, 33462 | |
Contact: Site Public Contact 561-964-2662 | |
Principal Investigator: Georges F. Hatoum | |
Morton Plant Hospital | Recruiting |
Clearwater, Florida, United States, 33756 | |
Contact: Site Public Contact 855-314-8646 | |
Principal Investigator: Roberto Diaz | |
Lee Memorial Health System | Recruiting |
Fort Myers, Florida, United States, 33901 | |
Contact: Site Public Contact 877-680-0008 | |
Principal Investigator: Kristina Mirabeau-Beale | |
Regional Cancer Center-Lee Memorial Health System | Recruiting |
Fort Myers, Florida, United States, 33905 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Kristina Mirabeau-Beale | |
Orlando Health Cancer Institute | Recruiting |
Orlando, Florida, United States, 32806 | |
Contact: Site Public Contact 321-841-7246 CancerClinicalTrials@orlandohealth.com | |
Principal Investigator: Patrick Kelly | |
GenesisCare USA - Plantation | Recruiting |
Plantation, Florida, United States, 33324 | |
Contact: Site Public Contact 941-833-5700 Rudi.Ross@usa.genesiscare.com | |
Principal Investigator: Frank A. Vicini | |
United States, Georgia | |
South Georgia Medical Center/Pearlman Cancer Center | Recruiting |
Valdosta, Georgia, United States, 31602 | |
Contact: Site Public Contact 229-259-4628 maryann.heddon@sgmc.org | |
Principal Investigator: Samuel N. Ofori | |
United States, Hawaii | |
The Cancer Center of Hawaii-Pali Momi | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-678-9000 | |
Principal Investigator: Samuel Birer | |
University of Hawaii Cancer Center | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-586-2979 | |
Principal Investigator: Samuel Birer | |
United States, Idaho | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Nitya Alluri | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Nitya Alluri | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Nitya Alluri | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Nitya Alluri | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Nitya Alluri | |
United States, Illinois | |
Rush - Copley Medical Center | Recruiting |
Aurora, Illinois, United States, 60504 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Kalika P. Sarma | |
Centralia Oncology Clinic | Recruiting |
Centralia, Illinois, United States, 62801 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Saint Mary's Hospital | Recruiting |
Centralia, Illinois, United States, 62801 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Jay W. Carlson | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: Eric D. Donnelly | |
John H Stroger Jr Hospital of Cook County | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-864-5204 | |
Principal Investigator: Thomas E. Lad | |
Carle at The Riverfront | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@Carle.com | |
Principal Investigator: Kalika P. Sarma | |
Cancer Care Specialists of Illinois - Decatur | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Decatur Memorial Hospital | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Cancer Center Kishwaukee | Recruiting |
DeKalb, Illinois, United States, 60115 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Eric D. Donnelly | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Kalika P. Sarma | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Cancer Center Delnor | Recruiting |
Geneva, Illinois, United States, 60134 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Eric D. Donnelly | |
Northwestern Medicine Lake Forest Hospital | Recruiting |
Lake Forest, Illinois, United States, 60045 | |
Contact: Site Public Contact cancertrials@northwestern.edu | |
Principal Investigator: Eric D. Donnelly | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Kalika P. Sarma | |
Loyola University Medical Center | Recruiting |
Maywood, Illinois, United States, 60153 | |
Contact: Site Public Contact 708-226-4357 | |
Principal Investigator: William Small | |
Cancer Care Center of O'Fallon | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
HSHS Saint Elizabeth's Hospital | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Southern Illinois University School of Medicine | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 217-545-7929 | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Memorial Medical Center | Recruiting |
Springfield, Illinois, United States, 62781 | |
Contact: Site Public Contact 217-528-7541 pallante.beth@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Kalika P. Sarma | |
Northwestern Medicine Cancer Center Warrenville | Recruiting |
Warrenville, Illinois, United States, 60555 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Eric D. Donnelly | |
Midwestern Regional Medical Center | Recruiting |
Zion, Illinois, United States, 60099 | |
Contact: Site Public Contact 844-793-0745 | |
Principal Investigator: Karan K. Shah | |
United States, Indiana | |
Northwest Cancer Center - Main Campus | Recruiting |
Crown Point, Indiana, United States, 46307 | |
Contact: Site Public Contact 219-310-2550 | |
Principal Investigator: Kalika P. Sarma | |
Northwest Oncology LLC | Recruiting |
Dyer, Indiana, United States, 46311 | |
Contact: Site Public Contact 219-924-8178 | |
Principal Investigator: Kalika P. Sarma | |
Goshen Center for Cancer Care | Recruiting |
Goshen, Indiana, United States, 46526 | |
Contact: Site Public Contact 574-364-2973 cccois@goshenhealth.com | |
Principal Investigator: James A. Wheeler | |
Northwest Cancer Center - Hobart | Recruiting |
Hobart, Indiana, United States, 46342 | |
Contact: Site Public Contact 219-947-1795 | |
Principal Investigator: Kalika P. Sarma | |
Saint Mary Medical Center | Recruiting |
Hobart, Indiana, United States, 46342 | |
Contact: Site Public Contact 219-836-6875 CancerResearch@COMHS.org | |
Principal Investigator: Kalika P. Sarma | |
The Community Hospital | Recruiting |
Munster, Indiana, United States, 46321 | |
Contact: Site Public Contact 219-836-3349 | |
Principal Investigator: Kalika P. Sarma | |
Women's Diagnostic Center - Munster | Recruiting |
Munster, Indiana, United States, 46321 | |
Contact: Site Public Contact 219-934-8869 mnicholson@comhs.org | |
Principal Investigator: Kalika P. Sarma | |
Reid Health | Recruiting |
Richmond, Indiana, United States, 47374 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Memorial Hospital of South Bend | Suspended |
South Bend, Indiana, United States, 46601 | |
Northwest Cancer Center - Valparaiso | Recruiting |
Valparaiso, Indiana, United States, 46383 | |
Contact: Site Public Contact 219-836-6875 CancerResearch@COMHS.org | |
Principal Investigator: Kalika P. Sarma | |
United States, Iowa | |
Mission Cancer and Blood - Ankeny | Recruiting |
Ankeny, Iowa, United States, 50023 | |
Contact: Site Public Contact 515-282-2921 | |
Principal Investigator: Richard L. Deming | |
Physicians' Clinic of Iowa PC | Recruiting |
Cedar Rapids, Iowa, United States, 52402 | |
Contact: Site Public Contact 319-297-2900 | |
Principal Investigator: Bharat Jenigiri | |
Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 515-241-3305 | |
Principal Investigator: Richard L. Deming | |
Mercy Cancer Center-West Lakes | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 515-358-6613 cancerresearch@mercydesmoines.org | |
Principal Investigator: Richard L. Deming | |
Greater Regional Medical Center | Recruiting |
Creston, Iowa, United States, 50801 | |
Contact: Site Public Contact 515-358-6613 cancerresearch@mercydesmoines.org | |
Principal Investigator: Richard L. Deming | |
Iowa Methodist Medical Center | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-6727 | |
Principal Investigator: Joshua Lukenbill | |
Medical Oncology and Hematology Associates-Des Moines | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-3305 | |
Principal Investigator: Joshua Lukenbill | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 515-358-6613 cancerresearch@mercydesmoines.org | |
Principal Investigator: Richard L. Deming | |
Mission Cancer and Blood - Laurel | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 515-241-3305 | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center-West Lakes | Recruiting |
West Des Moines, Iowa, United States, 50266 | |
Contact: Site Public Contact 515-358-6613 cancerresearch@mercydesmoines.org | |
Principal Investigator: Richard L. Deming | |
United States, Kansas | |
University of Kansas Cancer Center | Recruiting |
Kansas City, Kansas, United States, 66160 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Shane R. Stecklein | |
Olathe Health Cancer Center | Recruiting |
Olathe, Kansas, United States, 66061 | |
Contact: Site Public Contact 913-355-8000 Jeni.wakefield@olathehealth.org | |
Principal Investigator: Shane R. Stecklein | |
University of Kansas Cancer Center-Overland Park | Recruiting |
Overland Park, Kansas, United States, 66210 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Shane R. Stecklein | |
University of Kansas Hospital-Indian Creek Campus | Recruiting |
Overland Park, Kansas, United States, 66211 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Shane R. Stecklein | |
Salina Regional Health Center | Recruiting |
Salina, Kansas, United States, 67401 | |
Contact: Site Public Contact 785-452-7038 mleepers@srhc.com | |
Principal Investigator: Shane R. Stecklein | |
University of Kansas Health System Saint Francis Campus | Recruiting |
Topeka, Kansas, United States, 66606 | |
Contact: Site Public Contact 785-295-8000 | |
Principal Investigator: Shane R. Stecklein | |
University of Kansas Hospital-Westwood Cancer Center | Recruiting |
Westwood, Kansas, United States, 66205 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Shane R. Stecklein | |
United States, Maryland | |
Greater Baltimore Medical Center | Recruiting |
Baltimore, Maryland, United States, 21204 | |
Contact: Site Public Contact 443-849-3706 | |
Principal Investigator: Geoffrey A. Neuner | |
United States, Michigan | |
Henry Ford Cancer Institute-Downriver | Recruiting |
Brownstown, Michigan, United States, 48183 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Eleanor M. Walker | |
Michigan Healthcare Professionals Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 941-833-5700 rudi.ross@profoundresearch.io | |
Principal Investigator: Frank A. Vicini | |
Henry Ford Macomb Hospital-Clinton Township | Recruiting |
Clinton Township, Michigan, United States, 48038 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Eleanor M. Walker | |
Henry Ford Medical Center-Fairlane | Recruiting |
Dearborn, Michigan, United States, 48126 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Eleanor M. Walker | |
Henry Ford Hospital | Recruiting |
Detroit, Michigan, United States, 48202 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Eleanor M. Walker | |
Michigan Healthcare Professionals Farmington | Recruiting |
Farmington Hills, Michigan, United States, 48334 | |
Contact: Site Public Contact 941-833-5700 rudi.ross@profoundresearch.io | |
Principal Investigator: Frank A. Vicini | |
Genesys Hurley Cancer Institute | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 810-762-8038 wstrong@ghci.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hurley Medical Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 810-762-8038 wstrong@ghci.org | |
Principal Investigator: Tareq Al Baghdadi | |
Allegiance Health | Recruiting |
Jackson, Michigan, United States, 49201 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Eleanor M. Walker | |
Michigan Healthcare Professionals Macomb | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact rudi.ross@profoundresearch.io | |
Principal Investigator: Frank A. Vicini | |
Michigan Healthcare Professionals Madison Heights | Recruiting |
Madison Heights, Michigan, United States, 48071 | |
Contact: Site Public Contact 941-833-5700 rudi.ross@profoundresearch.io | |
Principal Investigator: Frank A. Vicini | |
Henry Ford Medical Center-Columbus | Recruiting |
Novi, Michigan, United States, 48377 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Eleanor M. Walker | |
Saint Joseph Mercy Oakland | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
William Beaumont Hospital-Royal Oak | Recruiting |
Royal Oak, Michigan, United States, 48073 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Peter Y. Chen | |
William Beaumont Hospital - Troy | Recruiting |
Troy, Michigan, United States, 48085 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Peter Y. Chen | |
GenesisCare USA - Troy | Recruiting |
Troy, Michigan, United States, 48098 | |
Contact: Site Public Contact rudi.ross@profoundresearch.io | |
Principal Investigator: Frank A. Vicini | |
Henry Ford West Bloomfield Hospital | Recruiting |
West Bloomfield, Michigan, United States, 48322 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Eleanor M. Walker | |
United States, Minnesota | |
Sanford Joe Lueken Cancer Center | Recruiting |
Bemidji, Minnesota, United States, 56601 | |
Contact: Site Public Contact 218-333-5000 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Daniel Almquist | |
Saint Luke's Hospital of Duluth | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-249-7825 kdean@slhduluth.com | |
Principal Investigator: Steven R. Bonin | |
United States, Mississippi | |
Baptist Memorial Hospital and Cancer Center-Golden Triangle | Recruiting |
Columbus, Mississippi, United States, 39705 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Michael Tomblyn | |
Baptist Cancer Center-Grenada | Recruiting |
Grenada, Mississippi, United States, 38901 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Michael Tomblyn | |
Baptist Memorial Hospital and Cancer Center-Union County | Recruiting |
New Albany, Mississippi, United States, 38652 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Michael Tomblyn | |
Baptist Memorial Hospital and Cancer Center-Oxford | Recruiting |
Oxford, Mississippi, United States, 38655 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Michael Tomblyn | |
Baptist Memorial Hospital and Cancer Center-Desoto | Recruiting |
Southhaven, Mississippi, United States, 38671 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Michael Tomblyn | |
United States, Missouri | |
Saint Francis Medical Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
Principal Investigator: Bryan A. Faller | |
Parkland Health Center - Farmington | Recruiting |
Farmington, Missouri, United States, 63640 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
University of Kansas Cancer Center - North | Recruiting |
Kansas City, Missouri, United States, 64154 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Shane R. Stecklein | |
University of Kansas Cancer Center - Lee's Summit | Recruiting |
Lee's Summit, Missouri, United States, 64064 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Shane R. Stecklein | |
University of Kansas Cancer Center at North Kansas City Hospital | Recruiting |
North Kansas City, Missouri, United States, 64116 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Shane R. Stecklein | |
Mercy Hospital South | Recruiting |
Saint Louis, Missouri, United States, 63128 | |
Contact: Site Public Contact 314-525-6042 Danielle.Werle@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Sainte Genevieve County Memorial Hospital | Recruiting |
Sainte Genevieve, Missouri, United States, 63670 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Springfield | Recruiting |
Springfield, Missouri, United States, 65804 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Sullivan Hospital | Recruiting |
Sullivan, Missouri, United States, 63080 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
BJC Outpatient Center at Sunset Hills | Recruiting |
Sunset Hills, Missouri, United States, 63127 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
United States, Montana | |
Billings Clinic Cancer Center | Recruiting |
Billings, Montana, United States, 59101 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
Nebraska Medicine-Bellevue | Recruiting |
Bellevue, Nebraska, United States, 68123 | |
Contact: Site Public Contact 402-559-6941 unmcrsa@unmc.edu | |
Principal Investigator: Andrew O. Wahl | |
Cancer Partners of Nebraska - Pine Lake | Recruiting |
Lincoln, Nebraska, United States, 68516 | |
Contact: Site Public Contact 402-327-7363 research@cancerpartners.com | |
Principal Investigator: Mark J. Stavas | |
Southeast Nebraska Cancer Center - 68th Street Place | Recruiting |
Lincoln, Nebraska, United States, 68516 | |
Contact: Site Public Contact 402-327-7363 research@cancerpartners.com | |
Principal Investigator: Mark J. Stavas | |
Nebraska Medicine-Village Pointe | Recruiting |
Omaha, Nebraska, United States, 68118 | |
Contact: Site Public Contact 402-559-5600 | |
Principal Investigator: Andrew O. Wahl | |
United States, New Hampshire | |
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center | Recruiting |
Lebanon, New Hampshire, United States, 03756 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@dartmouth.edu | |
Principal Investigator: Shauna McVorran | |
United States, New Jersey | |
Memorial Sloan Kettering Basking Ridge | Recruiting |
Basking Ridge, New Jersey, United States, 07920 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Diana Roth O'Brien | |
Memorial Sloan Kettering Monmouth | Recruiting |
Middletown, New Jersey, United States, 07748 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Diana Roth O'Brien | |
Memorial Sloan Kettering Bergen | Recruiting |
Montvale, New Jersey, United States, 07645 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Diana Roth O'Brien | |
United States, New York | |
Montefiore Medical Center-Einstein Campus | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Jana L. Fox | |
Montefiore Medical Center-Weiler Hospital | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Jana L. Fox | |
Montefiore Medical Center - Moses Campus | Recruiting |
Bronx, New York, United States, 10467 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Jana L. Fox | |
Sands Cancer Center | Recruiting |
Canandaigua, New York, United States, 14424 | |
Contact: Site Public Contact 585-396-6161 | |
Principal Investigator: Yuhchyau Chen | |
Memorial Sloan Kettering Commack | Recruiting |
Commack, New York, United States, 11725 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Diana Roth O'Brien | |
Noyes Memorial Hospital/Myers Cancer Center | Recruiting |
Dansville, New York, United States, 14437 | |
Contact: Site Public Contact WCICTOresearch@urmc.rochester.edu | |
Principal Investigator: Yuhchyau Chen | |
Memorial Sloan Kettering Westchester | Recruiting |
Harrison, New York, United States, 10604 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Diana Roth O'Brien | |
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center | Recruiting |
New York, New York, United States, 10032 | |
Contact: Site Public Contact 212-342-5162 cancerclinicaltrials@cumc.columbia.edu | |
Principal Investigator: Eileen P. Connolly | |
Memorial Sloan Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Diana Roth O'Brien | |
Wilmot Cancer Institute Radiation Oncology at Greece | Recruiting |
Rochester, New York, United States, 14606 | |
Contact: Site Public Contact 585-758-7877 | |
Principal Investigator: Yuhchyau Chen | |
Highland Hospital | Recruiting |
Rochester, New York, United States, 14620 | |
Contact: Site Public Contact 585-341-8113 | |
Principal Investigator: Yuhchyau Chen | |
Pluta Cancer Center | Recruiting |
Rochester, New York, United States, 14623 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Yuhchyau Chen | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Yuhchyau Chen | |
Stony Brook University Medical Center | Recruiting |
Stony Brook, New York, United States, 11794 | |
Contact: Site Public Contact 800-862-2215 | |
Principal Investigator: Alexander M. Stessin | |
Memorial Sloan Kettering Nassau | Recruiting |
Uniondale, New York, United States, 11553 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Diana Roth O'Brien | |
Wilmot Cancer Institute at Webster | Recruiting |
Webster, New York, United States, 14580 | |
Contact: Site Public Contact WCICTOresearch@urmc.rochester.edu | |
Principal Investigator: Yuhchyau Chen | |
United States, North Carolina | |
Wake Forest University Health Sciences | Recruiting |
Winston-Salem, North Carolina, United States, 27157 | |
Contact: Site Public Contact 336-713-6771 | |
Principal Investigator: Marissa M. Howard-McNatt | |
United States, North Dakota | |
Sanford Bismarck Medical Center | Recruiting |
Bismarck, North Dakota, United States, 58501 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Daniel Almquist | |
Sanford Broadway Medical Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Daniel Almquist | |
Sanford Roger Maris Cancer Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-234-6161 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Daniel Almquist | |
United States, Ohio | |
Indu and Raj Soin Medical Center | Recruiting |
Beavercreek, Ohio, United States, 45431 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Cleveland Clinic Mercy Hospital | Recruiting |
Canton, Ohio, United States, 44708 | |
Contact: Site Public Contact 888-293-4673 | |
Principal Investigator: Edward J. Walsh | |
Dayton Physicians LLC-Miami Valley South | Recruiting |
Centerville, Ohio, United States, 45459 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital South | Recruiting |
Centerville, Ohio, United States, 45459 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Jhansi L. Koduri | |
Ohio State University Comprehensive Cancer Center | Recruiting |
Columbus, Ohio, United States, 43210 | |
Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu | |
Principal Investigator: Sachin R. Jhawar | |
Dayton Blood and Cancer Center | Recruiting |
Dayton, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-276-8320 | |
Principal Investigator: Jhansi L. Koduri | |
Miami Valley Hospital | Recruiting |
Dayton, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Jhansi L. Koduri | |
Dayton Physician LLC-Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Jhansi L. Koduri | |
Atrium Medical Center-Middletown Regional Hospital | Recruiting |
Franklin, Ohio, United States, 45005-1066 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Jhansi L. Koduri | |
Dayton Physicians LLC-Atrium | Recruiting |
Franklin, Ohio, United States, 45005 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Cancer Care and Infusion | Recruiting |
Greenville, Ohio, United States, 45331 | |
Contact: Site Public Contact 937-569-7515 | |
Principal Investigator: Jhansi L. Koduri | |
Kettering Medical Center | Recruiting |
Kettering, Ohio, United States, 45429 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physicians LLC - Troy | Recruiting |
Troy, Ohio, United States, 45373 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Upper Valley Medical Center | Recruiting |
Troy, Ohio, United States, 45373 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Jhansi L. Koduri | |
United States, Oklahoma | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: Andrea Johnston | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
United States, Oregon | |
Saint Charles Health System | Recruiting |
Bend, Oregon, United States, 97701 | |
Contact: Site Public Contact 541-706-2909 nosall@stcharleshealthcare.org | |
Principal Investigator: Nitya Alluri | |
Clackamas Radiation Oncology Center | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Nitya Alluri | |
Providence Cancer Institute Clackamas Clinic | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Nitya Alluri | |
Legacy Mount Hood Medical Center | Recruiting |
Gresham, Oregon, United States, 97030 | |
Contact: Site Public Contact 503-413-2150 | |
Principal Investigator: Andrew Y. Kee | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Nitya Alluri | |
Providence Willamette Falls Medical Center | Recruiting |
Oregon City, Oregon, United States, 97045 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Nitya Alluri | |
Legacy Good Samaritan Hospital and Medical Center | Recruiting |
Portland, Oregon, United States, 97210 | |
Contact: Site Public Contact 800-220-4937 cancer@lhs.org | |
Principal Investigator: Andrew Y. Kee | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Nitya Alluri | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Nitya Alluri | |
Legacy Meridian Park Hospital | Recruiting |
Tualatin, Oregon, United States, 97062 | |
Contact: Site Public Contact 503-413-1742 | |
Principal Investigator: Andrew Y. Kee | |
United States, Pennsylvania | |
UPMC-Magee Womens Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15213 | |
Contact: Site Public Contact 412-647-2811 | |
Principal Investigator: Emilia J. Diego | |
United States, Rhode Island | |
Women and Infants Hospital | Recruiting |
Providence, Rhode Island, United States, 02905 | |
Contact: Site Public Contact 401-274-1122 | |
Principal Investigator: William M. Sikov | |
Kent Hospital | Recruiting |
Warwick, Rhode Island, United States, 02886 | |
Contact: Site Public Contact 401-737-7010 | |
Principal Investigator: Bachir J. Sakr | |
United States, South Carolina | |
Medical University of South Carolina | Recruiting |
Charleston, South Carolina, United States, 29425 | |
Contact: Site Public Contact 843-792-9321 hcc-clinical-trials@musc.edu | |
Principal Investigator: Harriet B. Eldredge-Hindy | |
Lexington Medical Center | Recruiting |
West Columbia, South Carolina, United States, 29169 | |
Contact: Site Public Contact 803-791-2105 LMCIRB@lexhealth.org | |
Principal Investigator: Steven A. Madden | |
United States, South Dakota | |
Sanford Cancer Center Oncology Clinic | Recruiting |
Sioux Falls, South Dakota, United States, 57104 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicTrialsSF@sanfordhealth.org | |
Principal Investigator: Daniel Almquist | |
Sanford USD Medical Center - Sioux Falls | Recruiting |
Sioux Falls, South Dakota, United States, 57117-5134 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicalTrialsSF@SanfordHealth.org | |
Principal Investigator: Daniel Almquist | |
United States, Tennessee | |
Baptist Memorial Hospital and Cancer Center-Collierville | Recruiting |
Collierville, Tennessee, United States, 38017 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Michael Tomblyn | |
Baptist Memorial Hospital and Cancer Center-Memphis | Recruiting |
Memphis, Tennessee, United States, 38120 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Michael Tomblyn | |
United States, Texas | |
MD Anderson in The Woodlands | Recruiting |
Conroe, Texas, United States, 77384 | |
Contact: Site Public Contact 866-632-6789 askmdanderson@mdanderson.org | |
Principal Investigator: Melissa P. Mitchell | |
M D Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 877-632-6789 askmdanderson@mdanderson.org | |
Principal Investigator: Melissa P. Mitchell | |
MD Anderson West Houston | Recruiting |
Houston, Texas, United States, 77079 | |
Contact: Site Public Contact 877-632-6789 askmdanderson@mdanderson.org | |
Principal Investigator: Melissa P. Mitchell | |
MD Anderson League City | Recruiting |
League City, Texas, United States, 77573 | |
Contact: Site Public Contact 877-632-6789 askmdanderson@mdanderson.org | |
Principal Investigator: Melissa P. Mitchell | |
MD Anderson in Sugar Land | Recruiting |
Sugar Land, Texas, United States, 77478 | |
Contact: Site Public Contact 877-632-6789 askmdanderson@mdanderson.org | |
Principal Investigator: Melissa P. Mitchell | |
United States, Utah | |
Farmington Health Center | Recruiting |
Farmington, Utah, United States, 84025 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Matthew M. Poppe | |
University of Utah Sugarhouse Health Center | Recruiting |
Salt Lake City, Utah, United States, 84106 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Matthew M. Poppe | |
Huntsman Cancer Institute/University of Utah | Recruiting |
Salt Lake City, Utah, United States, 84112 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Matthew M. Poppe | |
United States, Vermont | |
University of Vermont Medical Center | Recruiting |
Burlington, Vermont, United States, 05401 | |
Contact: Site Public Contact 802-656-4101 rpo@uvm.edu | |
Principal Investigator: Puyao Li | |
University of Vermont and State Agricultural College | Recruiting |
Burlington, Vermont, United States, 05405 | |
Contact: Site Public Contact 802-656-8990 rpo@uvm.edu | |
Principal Investigator: Puyao Li | |
Norris Cotton Cancer Center-North | Recruiting |
Saint Johnsbury, Vermont, United States, 05819 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@hitchcock.org | |
Principal Investigator: Shauna McVorran | |
United States, Virginia | |
Bon Secours Memorial Regional Medical Center | Recruiting |
Mechanicsville, Virginia, United States, 23116 | |
Contact: Site Public Contact 804-893-8978 anne_carmellat@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Saint Francis Medical Center | Recruiting |
Midlothian, Virginia, United States, 23114 | |
Contact: Site Public Contact 804-893-8978 anne_carmellat@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Saint Mary's Hospital | Recruiting |
Richmond, Virginia, United States, 23226 | |
Contact: Site Public Contact 804-893-8978 anne_carmellat@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Cancer Institute at Reynolds Crossing | Recruiting |
Richmond, Virginia, United States, 23230 | |
Contact: Site Public Contact 804-893-8978 Anne_caramella@bshsi.org | |
Principal Investigator: William J. Irvin | |
United States, Washington | |
Swedish Cancer Institute-Issaquah | Recruiting |
Issaquah, Washington, United States, 98029 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Nitya Alluri | |
Swedish Medical Center-Ballard Campus | Recruiting |
Seattle, Washington, United States, 98107 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Nitya Alluri | |
Swedish Medical Center-First Hill | Recruiting |
Seattle, Washington, United States, 98122 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Nitya Alluri | |
Legacy Cancer Institute Medical Oncology and Day Treatment | Recruiting |
Vancouver, Washington, United States, 98684 | |
Contact: Site Public Contact oncologyresearch@lhs.org | |
Principal Investigator: Andrew Y. Kee | |
Legacy Salmon Creek Hospital | Recruiting |
Vancouver, Washington, United States, 98686 | |
Contact: Site Public Contact 503-413-2150 | |
Principal Investigator: Andrew Y. Kee | |
United States, Wisconsin | |
Langlade Hospital and Cancer Center | Recruiting |
Antigo, Wisconsin, United States, 54409 | |
Contact: Site Public Contact 715-623-9869 Juli.Alford@aspirus.org | |
Principal Investigator: Andrew J. Huang | |
University of Wisconsin Carbone Cancer Center | Recruiting |
Madison, Wisconsin, United States, 53792 | |
Contact: Site Public Contact 800-622-8922 | |
Principal Investigator: Bethany M. Anderson | |
Froedtert Menomonee Falls Hospital | Recruiting |
Menomonee Falls, Wisconsin, United States, 53051 | |
Contact: Site Public Contact 262-257-5100 | |
Principal Investigator: Adam D. Currey | |
Medical College of Wisconsin | Recruiting |
Milwaukee, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-805-3666 | |
Principal Investigator: Adam D. Currey | |
ProHealth D N Greenwald Center | Recruiting |
Mukwonago, Wisconsin, United States, 53149 | |
Contact: Site Public Contact research.institute@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
Drexel Town Square Health Center | Recruiting |
Oak Creek, Wisconsin, United States, 53154 | |
Contact: Site Public Contact 414-805-0505 | |
Principal Investigator: Adam D. Currey | |
ProHealth Oconomowoc Memorial Hospital | Recruiting |
Oconomowoc, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 262-928-7878 | |
Principal Investigator: Timothy R. Wassenaar | |
Ascension Saint Mary's Hospital | Recruiting |
Rhinelander, Wisconsin, United States, 54501 | |
Contact: Site Public Contact 715-847-2353 Beth.Knetter@aspirus.org | |
Principal Investigator: Andrew J. Huang | |
Ascension Saint Michael's Hospital | Recruiting |
Stevens Point, Wisconsin, United States, 54481 | |
Contact: Site Public Contact 715-847-2353 Beth.Knetter@aspirus.org | |
Principal Investigator: Andrew J. Huang | |
UW Cancer Center at ProHealth Care | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-5539 Chanda.miller@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
Aspirus Regional Cancer Center | Recruiting |
Wausau, Wisconsin, United States, 54401 | |
Contact: Site Public Contact 877-405-6866 | |
Principal Investigator: Andrew J. Huang | |
Froedtert West Bend Hospital/Kraemer Cancer Center | Recruiting |
West Bend, Wisconsin, United States, 53095 | |
Contact: Site Public Contact 414-805-0505 | |
Principal Investigator: Adam D. Currey | |
Aspirus Cancer Care - Wisconsin Rapids | Recruiting |
Wisconsin Rapids, Wisconsin, United States, 54494 | |
Contact: Site Public Contact 715-422-7718 | |
Principal Investigator: Andrew J. Huang | |
Puerto Rico | |
Cancer Center-Metro Medical Center Bayamon | Recruiting |
Bayamon, Puerto Rico, 00959-5060 | |
Contact: Site Public Contact 787-395-7085 | |
Principal Investigator: Luis J. Santos Reyes | |
Doctors Cancer Center | Recruiting |
Manati, Puerto Rico, 00674 | |
Contact: Site Public Contact 787-621-4397 | |
Principal Investigator: Luis J. Santos Reyes | |
San Juan Community Oncology Group | Recruiting |
San Juan, Puerto Rico, 00917 | |
Contact: Site Public Contact 787-274-3387 | |
Principal Investigator: Luis J. Santos Reyes | |
Centro Comprensivo de Cancer de UPR | Recruiting |
San Juan, Puerto Rico, 00927 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Luis J. Santos Reyes | |
San Juan City Hospital | Recruiting |
San Juan, Puerto Rico, 00936 | |
Contact: Site Public Contact 787-763-1296 | |
Principal Investigator: Luis J. Santos Reyes |
Principal Investigator: | Norman Wolmark, MD | NRG Oncology |
Responsible Party: | NRG Oncology |
ClinicalTrials.gov Identifier: | NCT05705401 |
Other Study ID Numbers: |
NRG-BR008 5U10CA180868 ( U.S. NIH Grant/Contract ) NCI-2022-09157 ( Other Identifier: NCI ) |
First Posted: | January 30, 2023 Key Record Dates |
Last Update Posted: | April 2, 2024 |
Last Verified: | April 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |